JOINT FILING AGREEMENT

Exhibit 99.2

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, $0.001 par value per share, of Peregrine Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: November 27, 2017

	Ronin Trading, LLC
	By:	/s/ Xxxx X. Xxxxxxxx, III
		Name:	Xxxx X. Xxxxxxxx, III
		Title:	Manager

	Ronin Capital, LLC
	By:	/s/ Xxxx X. Xxxxxxxx, III
		Name:	Xxxx X. Xxxxxxxx, III
		Title:	Manager

/s/ Xxxx X. Xxxxxxxx, III

Xxxx X. Xxxxxxxx, III

	SWIM Partners LP
	By:	SW Investment Management LLC General Partner
	By:	/s/ Xxxxxxx Xxxxx
		Name:	Xxxxxxx Xxxxx
		Title:	Manager

	SW Investment Management LLC
	By:	/s/ Xxxxxxx Xxxxx
		Name:	Xxxxxxx Xxxxx
		Title:	Manager

/s/ Xxxxxxx Xxxxx

Xxxxxxx Xxxxx

/s/ Xxxxx Xxxxxx

Xxxxx Xxxxxx